GEODE CAPITAL MANAGEMENT, LLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 98 filers reported holding REPROS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$86,000
+109.8%
131,1120.0%0.00%
Q3 2017$41,000
-31.7%
131,1120.0%0.00%
Q2 2017$60,000
-62.5%
131,112
-1.9%
0.00%
Q1 2017$160,000
-8.6%
133,676
+0.3%
0.00%
Q4 2016$175,000
-31.9%
133,328
+8.0%
0.00%
Q3 2016$257,000
+29.8%
123,434
+0.0%
0.00%
Q2 2016$198,000
+38.5%
123,376
-16.3%
0.00%
Q1 2016$143,000
-7.7%
147,473
+14.8%
0.00%
Q4 2015$155,000
-83.7%
128,483
+0.1%
0.00%
-100.0%
Q3 2015$953,000
+3.9%
128,367
+0.1%
0.00%0.0%
Q2 2015$917,000
-20.5%
128,256
-4.6%
0.00%0.0%
Q1 2015$1,154,000
-9.0%
134,375
+5.6%
0.00%0.0%
Q4 2014$1,268,000
+7.0%
127,269
+6.3%
0.00%0.0%
Q3 2014$1,185,000
-42.1%
119,760
+1.2%
0.00%0.0%
Q2 2014$2,047,000
-1.6%
118,347
+0.9%
0.00%0.0%
Q1 2014$2,080,000
+2.3%
117,255
+5.5%
0.00%0.0%
Q4 2013$2,034,000
-26.0%
111,175
+8.4%
0.00%
-50.0%
Q3 2013$2,749,000
+93.7%
102,565
+33.3%
0.00%
+100.0%
Q2 2013$1,419,00076,9250.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,001,000$970,0000.21%
Allegis Investment Advisors, LLC 341,669$331,0000.19%
GENERAL AMERICAN INVESTORS CO INC 396,123$384,0000.04%
Alambic Investment Management, L.P. 114,591$111,0000.04%
Gruss Capital Management LP 600,000$582,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 102,086$99,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 323,429$314,0000.01%
GSA CAPITAL PARTNERS LLP 27,931$27,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$3,0000.00%
Airain ltd 13,690$13,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders